Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 7
1979 3
1980 1
1981 3
1982 3
1983 1
1985 1
1986 1
1987 1
1988 3
1989 1
1991 1
1992 3
1993 1
1995 1
1997 2
1999 1
2000 6
2002 3
2003 4
2004 1
2005 2
2006 5
2007 5
2009 1
2011 3
2012 2
2013 2
2014 1
2015 2
2016 3
2017 3
2019 6
2020 4
2021 5
2022 3
2023 3
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Another case of dyshidrosiform pemphigoid.
Patrizi A, Rizzoli L, Benassi L, Neri I. Patrizi A, et al. Among authors: benassi l. J Eur Acad Dermatol Venereol. 2003 May;17(3):370. doi: 10.1046/j.1468-3083.2003.00792_17.x. J Eur Acad Dermatol Venereol. 2003. PMID: 12702100 No abstract available.
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis.
Bessar H, Venditti I, Benassi L, Vaschieri C, Azzoni P, Pellacani G, Magnoni C, Botti E, Casagrande V, Federici M, Costanzo A, Fontana L, Testa G, Mostafa FF, Ibrahim SA, Russo MV, Fratoddi I. Bessar H, et al. Among authors: benassi l. Colloids Surf B Biointerfaces. 2016 May 1;141:141-147. doi: 10.1016/j.colsurfb.2016.01.021. Epub 2016 Jan 16. Colloids Surf B Biointerfaces. 2016. PMID: 26852097
Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination.
Ciérvide R, Montero Á, García-Rico E, García-Aranda M, Herrero M, Skaarup J, Benassi L, Barrera MJ, Vega E, Rojas B, Bratos R, Luna A, Parras M, López M, Delgado A, Quevedo P, Castilla S, Feyjoo M, Higueras A, Prieto M, Suarez-Gauthier A, Garcia-Cañamaque L, Escolán N, Álvarez B, Chen X, Alonso R, López M, Hernando O, Valero J, Sánchez E, Ciruelos E, Rubio C. Ciérvide R, et al. Among authors: benassi l. Cancers (Basel). 2022 Sep 19;14(18):4531. doi: 10.3390/cancers14184531. Cancers (Basel). 2022. PMID: 36139688 Free PMC article.
91 results